Basse dosi di ASA e FANS riducono rischio di CCR

Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.Friis S, Riis AH, Erichsen R, Baron JA, Sørensen HT.Ann Intern Med. 2015 Sep 1;163(5):347-55.   BACKGROUND:A recent comprehensive review concluded that additional research is needed to determine the optimal use of aspirin for cancer prevention. OBJECTIVE:To assess associations between the…